Macquarie Group LTD Applied Genetic Technologies Corp Transaction History

Macquarie Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$2.62 - $4.44 $8,811 - $14,931	-3,363 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$2.28 - $7.15 $12,948 - $40,604	-5,679 Reduced 62.81%	3,363 $8,000
Q3 2018 Nov 15, 2018	SELL	$3.85 - $7.35 $22,006 - $42,012	-5,716 Reduced 38.73%	9,042 $66,000
Q2 2018 Aug 14, 2018	BUY	$3.7 - $5.65 $17,390 - $26,555	4,700 Added 46.73%	14,758 $55,000
Q1 2018 May 11, 2018	SELL	$3.65 - $5.2 $4,380 - $6,240	-1,200 Reduced 10.66%	10,058 $39,000
Q4 2017 Feb 15, 2018	BUY	$3.4 - $4.15 $12,501 - $15,259	3,677 Added 48.5%	11,258 $41,000
Q3 2017 Nov 08, 2017	BUY	$3.55 - $5.25 $26,912 - $39,800	7,581	7,581 $30,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.